Literature DB >> 14648213

Quality control requirements in neonatal screening.

Toni Torresani1.   

Abstract

UNLABELLED: One of the key tasks for the persons in charge of a neonatal screening laboratory is the control and maintenance of the quality of analytical results. The process of examining every day hundreds of blood spot samples obtained from newborn babies in order to divide the population of neonates into a low risk group and a high risk group, presents several challenges with respect to organisation, analytical accuracy and precision and effectiveness in the recall and treatment procedures. Quality in neonatal screening is not determined solely by the analytical performance of the laboratory; all the steps of the neonatal screening "system" contribute to the overall quality and performance.
CONCLUSIONS: Programmes for the monitoring of the quality of neonatal screening have to be multidisciplinary and not restricted to the laboratory alone; not only analytical performance, but also the procedures used throughout the programme have to be monitored.

Entities:  

Mesh:

Year:  2003        PMID: 14648213     DOI: 10.1007/s00431-003-1353-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  3 in total

1.  Revised guidelines for neonatal screening programmes for primary congenital hypothyroidism. Working Group on Neonatal Screening of the European Society for Paediatric Endocrinology.

Authors: 
Journal:  Horm Res       Date:  1999

2.  Procedure for neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors: 
Journal:  Horm Res       Date:  2001

3.  Designing quality control for neonatal screening assays.

Authors:  Else-Maj R Suolinna; Toni E Torresani; James O Westgard
Journal:  Southeast Asian J Trop Med Public Health       Date:  2003       Impact factor: 0.267

  3 in total
  1 in total

1.  Quality performance of newborn screening systems: strategies for improvement.

Authors:  D Webster
Journal:  J Inherit Metab Dis       Date:  2007-08-14       Impact factor: 4.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.